These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18700641)

  • 1. Lipoatrophy at insulin injection site.
    Velayutham P; Shriraam M; Bhadada S; Bhansali A
    J Assoc Physicians India; 2008 May; 56():335. PubMed ID: 18700641
    [No Abstract]   [Full Text] [Related]  

  • 2. Injection site lipoatrophy: a rare complication of recombinant human insulin.
    Chakraborty PP; Bhattacharjee R
    J Assoc Physicians India; 2010 Oct; 58():630. PubMed ID: 21510114
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin-induced localized lipoatrophy.
    Breznik V; Kokol R; Luzar B; Miljković J
    Acta Dermatovenerol Alp Pannonica Adriat; 2013 Dec; 22(4):83-5. PubMed ID: 24336944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distant site lipoatrophy: a rare complication of subcutaneous insulin therapy.
    Chakraborty PP; Biswas SN
    Postgrad Med J; 2016 Jan; 92(1083):57-8. PubMed ID: 26561591
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of lipoatrophy with insulin detemir.
    Del Olmo MI; Campos V; Abellán P; Merino-Torres JF; Piñón F
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e20-1. PubMed ID: 18281121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-insulin allergy and severe lipoatrophy complicating Type 2 diabetes.
    Tavare AN; Doolittle HJ; Baburaj R
    Diabet Med; 2011 Apr; 28(4):500-3. PubMed ID: 21392071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoatrophy induced by recombinant human insulin injection.
    Murao S; Hirata K; Ishida T; Takahara J
    Intern Med; 1998 Dec; 37(12):1031-3. PubMed ID: 9932635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotted dermopathy in a diabetic patient due to insulin allergy.
    Maheshwari M; Goyal D; Desouza P; Goyal RK
    J Assoc Physicians India; 2004 Nov; 52():926-7. PubMed ID: 15906848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodules of fibrocollagenous scar tissue induced by subcutaneous insulin injections: a cause of poor diabetic control.
    Wallymahmed ME; Littler P; Clegg C; Haqqani MT; Macfarlane IA
    Postgrad Med J; 2004 Dec; 80(950):732-3. PubMed ID: 15579616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoatrophy is a thing of the past, or is it?
    Hussein SF; Siddique H; Coates P; Green J
    Diabet Med; 2007 Dec; 24(12):1470-2. PubMed ID: 17976201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobular panniculitis at the site of glatiramer acetate injections for the treatment of relapsing-remitting multiple sclerosis. A report of two cases.
    Ball NJ; Cowan BJ; Moore GR; Hashimoto SA
    J Cutan Pathol; 2008 Apr; 35(4):407-10. PubMed ID: 18333902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipoatrophy after insulin injections can be treated with lipofilling].
    Lund PS; Sjøstrand H; Matzen SH
    Ugeskr Laeger; 2016 Dec; 178(49):. PubMed ID: 27959262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized abdominal idiopathic lipodystrophy.
    Serrão VV; Feio AB
    Dermatol Online J; 2008 Jul; 14(7):15. PubMed ID: 18718199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Soft tumors in the mid abdomen and thighs. Diabetes, lipohypertrophy].
    Winter M
    MMW Fortschr Med; 2011 Oct; 153(43):5. PubMed ID: 22097618
    [No Abstract]   [Full Text] [Related]  

  • 15. Lispro insulin-induced lipoatrophy: a new case.
    Al-Khenaizan S; Al Thubaiti M; Al Alwan I
    Pediatr Diabetes; 2007 Dec; 8(6):393-6. PubMed ID: 18036067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
    Bazzano LA; Lee LJ; Shi L; Reynolds K; Jackson JA; Fonseca V
    Diabet Med; 2008 Aug; 25(8):924-32. PubMed ID: 18959605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe lipoatrophy with insulin in type 1 diabetes.
    Ma X; Lv H; Li Q; Shen J
    J Dermatol; 2012 Jun; 39(6):578-9. PubMed ID: 22097884
    [No Abstract]   [Full Text] [Related]  

  • 18. Membranous lipodystrophy associated with insulin lipoatrophy.
    Kim KT; Ahn SK; Choi EH; Lee SH
    Int J Dermatol; 1997 Apr; 36(4):299-301. PubMed ID: 9169335
    [No Abstract]   [Full Text] [Related]  

  • 19. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
    Fajardo Montañana C; Hernández Herrero C; Rivas Fernández M
    Diabet Med; 2008 Aug; 25(8):916-23. PubMed ID: 18959604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.